Business · 04/10/2005
FDA Opens Public Workshop on Rare Plasma Protein Disorders for Public Comment
The FDA is seeking public input on the development of treatments for rare plasma protein disorders, following a 2005 workshop, and is making workshop presentations available for review.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →